Form D · Biotechnology
REPLICATE Dental Technologies PLC
Dublin 2, L2 · CIK 0001763481
Offering snapshot reported Aug 23, 2019 · SEC filing
- Reported sold
- $144K Offering amount: $850K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Aug 12, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 23, 2019 | Initial | $144,035 | No comparison | 13 | SEC filing |
| Jan 8, 2019 | Initial | $207,000 | No comparison | 4 | SEC filing |
| Jan 4, 2019 | Initial | $0 | No comparison | 119 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-347327
Source: Form D, filed Aug 23, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Barbieri | Director |
| Roger Bendisch | Director |
| Lea Ann Ellermeier | Director, Executive |
| Gerald Glasauer | Director |
| James Lafferty | Director |
| Friedrich Riemeier | Director |
| Ruedger Rubbert | Director |
| Robert Skogstad | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Riverside One Sir John Rogerson's Quay
Dublin 2, L2, D02 X576
Dublin 2, L2, D02 X576